Home News Insights Trading halts Paper trading Guide Community My account

Market calendarChecking market schedule

Display in USD

Loading news article.

About WAPE
U.S. stock guide
Scanner guide
Paper trading guide
Terms of service
Privacy policy
Announcements
FAQ

Support: help@wapeb.comPartnerships: partnership@wapeb.com

WAPE is a free research, analysis and paper trading service. It does not place real securities orders. Market data and AI summaries are for information only, not investment advice or stock recommendations. Information may include delays, errors or estimates. Check original sources and supporting materials. You are responsible for your investment decisions and any resulting gains or losses.

Language한국어 English

Loading news article.

BlossomHill Therapeutics Announces Upcoming Poster Presentation for BH-30236 at ASH Annual Meeting | WAPE

Back All news

Newsfiscal.ai

BlossomHill Therapeutics Announces Upcoming Poster Presentation for BH-30236 at ASH Annual Meeting

Nov 4, 2026, 09:03 ET · Published

View source

Article summary

BlossomHill Therapeutics will present preclinical and clinical data for its CLK inhibitor, BH-30236, at the 68th American Society of Hematology Annual Meeting in December 2026.

An excerpt from the original article.

Related companies

BlossomHill Therapeutics, Inc. Common StockBLSMView stock

BlossomHill Therapeutics Announces Upcoming Poster Presentation for BH-30236 at ASH Annual Meeting

Article summary

Related companies

Analyzed by WAPE AI.

Comments —